InjectCo serves patients across the United States through its online weight loss program
Diet as a risk factor for the development of ulcerative colitis
The FDA-approved product contains only tirzepatide in its specified concentrations (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection)
These GLP-1 drugs, including semaglutide and tirzepatide, have shown 15-25% body weight reduction in clinical trials, approaching the effectiveness of surgery
This includes assessment of tissue resilience, inflammatory signaling, and regenerative capacity at the cellular level
mostly its the coordination of them thats causing problems